Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121959) titled 'A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Merck Sharp & Dohme LLC
Condition:
Healthy
Intervention:
Drug: Metformin
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: August 18, 2025
Target Sample Size: 14
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121959
Published by HT Digital ...